ÂÜÀòÂÒÂ×

Lih-Yun Hsu is an accomplished immunologist with extensive experience in both industry and academia. Currently serving as the Director of Immunology at Corvus Pharmaceuticals since November 2021, Lih-Yun Hsu manages a team focused on advancing pre-clinical programs and therapeutic hypotheses while supporting activities for IND filing. Previously, Lih-Yun Hsu worked as a Staff Scientist at Kyverna Therapeutics, contributing to pipeline programs for autoimmune diseases, and held the position of Principal Scientist at Pfizer, where expertise was applied in CART cell studies, cytokine therapy, and drug discovery. Lih-Yun Hsu's academic background includes significant roles at UCSF as Senior Scientist and Adjunct Assistant Professor, leading research on T cell behavior in autoimmune models. Lih-Yun Hsu earned a Ph.D. in Immunology from The Johns Hopkins University.